Digital Therapeutics Market Advanced Technologies and Rising Demand Led by 2Morrow, Fitbit, MANGO HEALTH, Omada Health, CANARY HEALTH, Noom, Proteus Digital Health

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant rate in Asia Pacific (APAC) region during the forecast period. Factors such as, increasing prevalence of the chronic diseases, acceptance of the digital health platforms, developments performed by the market players in the countries such as India, China, Australia and others are likely to propel growth of the market.

The digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.

Download sample PDF Brochure @ https://www.theinsightpartners.com/sample/TIPHC00002236/?openpr-10144

The major players operating in the digital therapeutics market include Propeller Health, CANARY HEALTH, Noom, Inc., 2Morrow Inc., Livongo Health, Proteus Digital Health, WellDoc, Inc., Fitbit, Inc., Omada Health, Inc., and MANGO HEALTH and among others.

Global digital therapeutics market is expected to grow in the coming years, owing to the rising pressure on healthcare providers to reduce healthcare cost in the market. The fiscal pressure and patent cliffs compel healthcare providers to cut on drug prices, encourage the use of generics and scale back the reimbursement. This in turn is gradually reducing the profit margins and annual net sales of the healthcare companies that leads to immediate requirement of a strategic plan so as to cut down on the operational costs.

Digital therapeutics help in reducing the costs associated with chronic diseases, by helping an individual or an insurance provider to keep a track of one’s health status as well as track it with the help of digital means. As per American Diabetes Association, the estimated costs of diagnosed diabetes have risen to $327 billion in 2017, including $237 billion in direct medical costs and $90 billion in reduced productivity. This cost can be managed efficiently by including digital therapeutics that are offered by providers to help manage diabetes, can help patients get assistance with disease management and overcome the logistical challenges uncovered by the investigators.

For instance, according to IDF Diabetes Atlas published by the International Diabetes Federation in 2017, south-east Asia is home to approximately one-fifth (19%) of the total diabetes population worldwide. According to the report of American College of Cardiology Foundation, in 2018, Coronary heart disease (CHD) was the leading cause of deaths attributable to cardiovascular disease (CVD) in the US, which is followed by stroke (16.8%), high BP (9.4%), heart failure (HF) (9.0%), and other CVDs (17.9%). By 2035, approximately 130 million adults in the US population are projected to have some form of CVD. Thus, increasing geriatric population and related chronic diseases are expected to propel the growth of global digital therapeutics market over the forecast years.

Inquiry Before Buying @ https://www.theinsightpartners.com/inquiry/TIPHC00002236/?opepr-10144

TABLE OF CONTENTS

1. INTRODUCTION 18
1.1 SCOPE OF THE STUDY 18
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 18

2. GLOBAL DIGITAL THERAPEUTICS MARKET - KEY TAKEAWAYS 19

3. GLOBAL DIGITAL THERAPEUTICS MARKET - MARKET LANDSCAPE 21
3.1 OVERVIEW 21
3.2 MARKET SEGMENTATION 21
3.2.1 Global Digital Therapeutics Market- By Application 22
3.2.2 Global Digital Therapeutics Market - By Distribution Channel 22
3.2.3 Global Digital Therapeutics Market - By Geography 23
3.3 PEST ANALYSIS 24
3.3.1 North America - PEST Analysis 24
3.3.2 Europe - PEST Analysis 26
3.3.3 Asia Pacific - PEST Analysis 28
3.3.4 Middle East and Africa (MEA) - PEST Analysis 30
3.3.5 South and Central America - PEST Analysis 32

4. GLOBAL DIGITAL THERAPEUTICS MARKET - KEY MARKET DYNAMICS 34
4.1 KEY MARKET DRIVERS 34
4.1.1 Rising Prevalence of Chronic Diseases 34
4.1.2 Rising Pressure on Healthcare Providers to Reduce Healthcare Costs 35
4.1.3 Rising in the Number of Partnerships and Collaborations in the Market 35
4.2 KEY MARKET RESTRAINTS 36
4.2.1 Cyber Threat and Rise in Data Security 36
4.3 KEY MARKET OPPORTUNITY 36
4.3.1 Large Number of Undiagnosed Population 36
4.4 FUTURE TREND 38
4.4.1 Increase in the Number of Start Ups 38
4.5 IMPACT ANALYSIS 39

5. DIGITAL THERAPEUTICS MARKET- GLOBAL ANALYSIS 40
5.1 GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN) 40
5.2 GLOBAL DIGITAL THERAPEUTICS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 41
5.3 PROMINENT PLAYERS 42
5.4 PERFORMANCE OF KEY PLAYERS 42
5.4.1 Propeller Health 42
5.4.2 CANARY HEALTH 42
5.5 EXPERT OPINIONS 43

Buy Complete Report @ https://www.theinsightpartners.com/buy/TIPHC00002236/?openpr-10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.